Annual CFF
-$87.98 M
+$23.87 M+21.34%
31 December 2023
Summary:
Genmab A/S annual cash flow from financing activities is currently -$87.98 million, with the most recent change of +$23.87 million (+21.34%) on 31 December 2023. During the last 3 years, it has fallen by -$98.86 million (-908.76%). GMAB annual CFF is now -116.03% below its all-time high of $548.79 million, reached on 31 December 2019.GMAB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$51.71 M
+$387.90 M+88.24%
01 September 2024
Summary:
Genmab A/S quarterly cash flow from financing activities is currently -$51.71 million, with the most recent change of +$387.90 million (+88.24%) on 01 September 2024. Over the past year, it has dropped by -$54.71 million (-1827.72%). GMAB quarterly CFF is now -109.55% below its all-time high of $541.62 million, reached on 30 September 2019.GMAB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$580.69 M
-$54.71 M-10.40%
01 September 2024
Summary:
Genmab A/S TTM cash flow from financing activities is currently -$580.69 million, with the most recent change of -$54.71 million (-10.40%) on 01 September 2024. Over the past year, it has dropped by -$508.11 million (-700.06%). GMAB TTM CFF is now -205.07% below its all-time high of $552.68 million, reached on 31 March 2020.GMAB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GMAB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.3% | -1827.7% | -700.1% |
| 3 y3 years | -908.8% | -1053.2% | -804.3% |
| 5 y5 years | -682.3% | -109.5% | -206.7% |
GMAB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -908.8% | +21.3% | -507.1% | +88.2% | -1710.1% | at low |
| 5 y | 5 years | -116.0% | +21.3% | -109.5% | +88.2% | -205.1% | at low |
| alltime | all time | -116.0% | +21.3% | -109.5% | +88.2% | -205.1% | at low |
Genmab A/S Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$51.71 M(-88.2%) | -$580.69 M(+10.4%) |
| June 2024 | - | -$439.61 M(+407.2%) | -$525.99 M(+507.8%) |
| Mar 2024 | - | -$86.67 M(+3110.9%) | -$86.53 M(-1.6%) |
| Dec 2023 | -$87.98 M(-21.3%) | -$2.70 M(-190.2%) | -$87.98 M(+21.2%) |
| Sept 2023 | - | $2.99 M(-1943.0%) | -$72.58 M(-54.7%) |
| June 2023 | - | -$162.40 K(-99.8%) | -$160.33 M(-15.8%) |
| Mar 2023 | - | -$88.11 M(-793.6%) | -$190.31 M(+70.1%) |
| Dec 2022 | -$111.85 M(+67.4%) | $12.70 M(-115.0%) | -$111.85 M(-8.5%) |
| Sept 2022 | - | -$84.75 M(+181.2%) | -$122.26 M(+281.1%) |
| June 2022 | - | -$30.14 M(+212.2%) | -$32.08 M(-21.4%) |
| Mar 2022 | - | -$9.65 M(-521.1%) | -$40.82 M(-38.9%) |
| Dec 2021 | -$66.83 M(-714.3%) | $2.29 M(-57.7%) | -$66.83 M(+4.1%) |
| Sept 2021 | - | $5.42 M(-114.0%) | -$64.21 M(-3.4%) |
| June 2021 | - | -$38.88 M(+9.0%) | -$66.48 M(+146.2%) |
| Mar 2021 | - | -$35.66 M(-826.5%) | -$27.00 M(-348.2%) |
| Dec 2020 | $10.88 M(-98.0%) | $4.91 M(+55.2%) | $10.88 M(+1.4%) |
| Sept 2020 | - | $3.16 M(+434.8%) | $10.73 M(-98.0%) |
| June 2020 | - | $591.50 K(-73.3%) | $549.19 M(-0.6%) |
| Mar 2020 | - | $2.21 M(-53.5%) | $552.68 M(+0.7%) |
| Dec 2019 | $548.79 M(-4979.5%) | $4.76 M(-99.1%) | $548.79 M(+0.9%) |
| Sept 2019 | - | $541.62 M(>+9900.0%) | $544.11 M(>+9900.0%) |
| June 2019 | - | $4.08 M(-343.8%) | $4.86 M(-40.5%) |
| Mar 2019 | - | -$1.67 M(-2297.0%) | $8.17 M(-172.6%) |
| Dec 2018 | -$11.25 M(-134.4%) | $76.20 K(-96.8%) | -$11.25 M(-2.2%) |
| Sept 2018 | - | $2.38 M(-67.8%) | -$11.50 M(+19.5%) |
| June 2018 | - | $7.39 M(-135.0%) | -$9.62 M(+204.6%) |
| Mar 2018 | - | -$21.09 M(>+9900.0%) | -$3.16 M(-109.7%) |
| Dec 2017 | $32.73 M(+141.5%) | -$181.60 K(-104.3%) | $32.73 M(-10.6%) |
| Sept 2017 | - | $4.26 M(-69.3%) | $36.63 M(+23.0%) |
| June 2017 | - | $13.85 M(-6.4%) | $29.77 M(+31.3%) |
| Mar 2017 | - | $14.80 M(+298.0%) | $22.67 M(+67.3%) |
| Dec 2016 | $13.55 M(-85.8%) | $3.72 M(-243.3%) | $13.55 M(-17.4%) |
| Sept 2016 | - | -$2.59 M(-138.4%) | $16.41 M(-56.1%) |
| June 2016 | - | $6.76 M(+19.0%) | $37.41 M(-29.8%) |
| Mar 2016 | - | $5.67 M(-13.7%) | $53.32 M(-44.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $95.67 M(-48.2%) | $6.58 M(-64.2%) | $95.67 M(+2.6%) |
| Sept 2015 | - | $18.40 M(-18.8%) | $93.24 M(+31.0%) |
| June 2015 | - | $22.66 M(-52.8%) | $71.19 M(+43.5%) |
| Mar 2015 | - | $48.03 M(+1058.1%) | $49.63 M(-73.1%) |
| Dec 2014 | $184.67 M(+583.8%) | $4.15 M(-213.7%) | $184.67 M(-5.2%) |
| Sept 2014 | - | -$3.65 M(-432.3%) | $194.81 M(-2.8%) |
| June 2014 | - | $1.10 M(-99.4%) | $200.46 M(-2.2%) |
| Mar 2014 | - | $183.07 M(+1181.3%) | $205.03 M(+659.2%) |
| Dec 2013 | $27.01 M(-56.3%) | $14.29 M(+610.8%) | $27.01 M(-64.1%) |
| Sept 2013 | - | $2.01 M(-64.5%) | $75.26 M(+3.0%) |
| June 2013 | - | $5.66 M(+12.2%) | $73.04 M(+8.8%) |
| Mar 2013 | - | $5.04 M(-91.9%) | $67.11 M(+8.6%) |
| Dec 2012 | $61.79 M(-5530.8%) | $62.54 M(<-9900.0%) | $61.79 M(-6143.2%) |
| Sept 2012 | - | -$206.00 K(-24.0%) | -$1.02 M(-6.6%) |
| June 2012 | - | -$271.00 K(-0.1%) | -$1.09 M(-3.0%) |
| Mar 2012 | - | -$271.40 K(-1.0%) | -$1.13 M(-0.8%) |
| Dec 2011 | -$1.14 M(-8.8%) | -$274.10 K(-1.5%) | -$1.14 M(-4.7%) |
| Sept 2011 | - | -$278.30 K(-8.6%) | -$1.19 M(-2.0%) |
| June 2011 | - | -$304.60 K(+8.4%) | -$1.22 M(+3.4%) |
| Mar 2011 | - | -$280.90 K(-14.9%) | -$1.18 M(-5.6%) |
| Dec 2010 | -$1.25 M(+0.3%) | -$329.90 K(+8.9%) | -$1.25 M(-1.7%) |
| Sept 2010 | - | -$302.90 K(+14.7%) | -$1.27 M(-8.1%) |
| June 2010 | - | -$264.00 K(-24.6%) | -$1.38 M(-8.7%) |
| Mar 2010 | - | -$350.30 K(-0.3%) | -$1.51 M(+21.5%) |
| Dec 2009 | -$1.24 M(-125.0%) | -$351.40 K(-15.2%) | -$1.24 M(+39.4%) |
| Sept 2009 | - | -$414.30 K(+4.9%) | -$891.90 K(+86.7%) |
| June 2009 | - | -$394.90 K(+377.5%) | -$477.60 K(+477.5%) |
| Mar 2009 | - | -$82.70 K | -$82.70 K |
| Dec 2008 | $4.98 M(-98.3%) | - | - |
| Dec 2007 | $286.92 M(+93.8%) | - | - |
| Dec 2006 | $148.05 M(+198.1%) | - | - |
| Dec 2005 | $49.67 M(-41.0%) | - | - |
| Dec 2004 | $84.20 M(<-9900.0%) | - | - |
| Dec 2003 | -$543.60 K(-102.7%) | - | - |
| Dec 2002 | $19.96 M | - | - |
FAQ
- What is Genmab A/S annual cash flow from financing activities?
- What is the all time high annual CFF for Genmab A/S?
- What is Genmab A/S annual CFF year-on-year change?
- What is Genmab A/S quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Genmab A/S?
- What is Genmab A/S quarterly CFF year-on-year change?
- What is Genmab A/S TTM cash flow from financing activities?
- What is the all time high TTM CFF for Genmab A/S?
- What is Genmab A/S TTM CFF year-on-year change?
What is Genmab A/S annual cash flow from financing activities?
The current annual CFF of GMAB is -$87.98 M
What is the all time high annual CFF for Genmab A/S?
Genmab A/S all-time high annual cash flow from financing activities is $548.79 M
What is Genmab A/S annual CFF year-on-year change?
Over the past year, GMAB annual cash flow from financing activities has changed by +$23.87 M (+21.34%)
What is Genmab A/S quarterly cash flow from financing activities?
The current quarterly CFF of GMAB is -$51.71 M
What is the all time high quarterly CFF for Genmab A/S?
Genmab A/S all-time high quarterly cash flow from financing activities is $541.62 M
What is Genmab A/S quarterly CFF year-on-year change?
Over the past year, GMAB quarterly cash flow from financing activities has changed by -$54.71 M (-1827.72%)
What is Genmab A/S TTM cash flow from financing activities?
The current TTM CFF of GMAB is -$580.69 M
What is the all time high TTM CFF for Genmab A/S?
Genmab A/S all-time high TTM cash flow from financing activities is $552.68 M
What is Genmab A/S TTM CFF year-on-year change?
Over the past year, GMAB TTM cash flow from financing activities has changed by -$508.11 M (-700.06%)